PT  - JOURNAL ARTICLE
AU  - Vinall, Maria
ED  - Genant, Harry K
TI  - Results from the Long-Term Extension of the AIM Trial
DP  - 2006 Oct 01
TA  - MD Conference Express
PG  - 13--13
VI  - 6
IP  - 3
4099  - http://mdc.sagepub.com/content/6/3/13.1.short
4100  - http://mdc.sagepub.com/content/6/3/13.1.full
AB  - The results from the 2-year AIM (ABA in Inadequate responders to MTX) trial indicated that RA patients refractory to treatment with MTX, demonstrate significant reduction in radiographic progression after treatment with Abatacept [Ann Rheum Dis 2005;64(Suppl III):56].